Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Anne Fuhlbrigge

Concepts (429)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Asthma
98
2025
1889
9.700
 Why?
Anti-Asthmatic Agents
28
2025
266
3.400
 Why?
Adrenal Cortex Hormones
28
2025
496
3.370
 Why?
Forced Expiratory Volume
19
2019
482
1.570
 Why?
Pulmonary Disease, Chronic Obstructive
11
2022
1030
1.370
 Why?
Severity of Illness Index
20
2020
2865
0.980
 Why?
Administration, Inhalation
25
2025
595
0.970
 Why?
Anti-Inflammatory Agents
10
2016
475
0.880
 Why?
Albuterol
5
2015
74
0.850
 Why?
Bronchodilator Agents
12
2016
197
0.840
 Why?
Lung Transplantation
10
2017
336
0.820
 Why?
Budesonide
14
2016
56
0.810
 Why?
Remote Consultation
4
2025
54
0.770
 Why?
Nedocromil
11
2016
23
0.720
 Why?
Humans
129
2025
139073
0.710
 Why?
Self Report
3
2023
840
0.700
 Why?
Nasal Polyps
1
2021
61
0.700
 Why?
Endpoint Determination
2
2020
78
0.680
 Why?
Pharmacogenetics
2
2015
165
0.680
 Why?
Food Hypersensitivity
1
2022
182
0.620
 Why?
Sinusitis
1
2021
232
0.600
 Why?
Virus Diseases
1
2021
214
0.590
 Why?
Lung
7
2019
4094
0.580
 Why?
Glucocorticoids
4
2022
532
0.580
 Why?
Physicians
2
2021
929
0.570
 Why?
Symptom Assessment
1
2019
129
0.560
 Why?
Hospitalization
13
2020
2224
0.560
 Why?
Sleep Apnea, Obstructive
1
2021
310
0.530
 Why?
Androstadienes
3
2012
78
0.520
 Why?
Child
53
2022
21907
0.510
 Why?
Bone Density
2
2014
490
0.500
 Why?
Disease Progression
14
2020
2741
0.500
 Why?
Oxygen Inhalation Therapy
4
2020
171
0.500
 Why?
Managed Care Programs
8
2008
140
0.490
 Why?
Male
82
2025
68330
0.490
 Why?
Emergency Service, Hospital
9
2013
2106
0.490
 Why?
Adult
47
2025
38394
0.480
 Why?
Precision Medicine
1
2020
419
0.480
 Why?
Female
81
2025
74078
0.460
 Why?
Patient Reported Outcome Measures
1
2018
408
0.450
 Why?
Adrenergic beta-2 Receptor Agonists
4
2020
27
0.450
 Why?
Cost Savings
1
2015
84
0.450
 Why?
Practice Patterns, Physicians'
7
2020
1315
0.440
 Why?
Peak Expiratory Flow Rate
2
2011
25
0.410
 Why?
Middle Aged
40
2025
33867
0.410
 Why?
Cost-Benefit Analysis
7
2022
605
0.410
 Why?
Phenotype
6
2025
3160
0.390
 Why?
Comorbidity
4
2021
1656
0.360
 Why?
Academic Medical Centers
3
2024
512
0.350
 Why?
Adolescent
37
2019
21561
0.340
 Why?
Surveys and Questionnaires
14
2022
5892
0.340
 Why?
Administration, Oral
6
2021
790
0.340
 Why?
Medical Records Systems, Computerized
3
2008
95
0.340
 Why?
Quality of Life
12
2023
2954
0.330
 Why?
Mentors
1
2012
210
0.330
 Why?
Respiratory Function Tests
10
2015
559
0.320
 Why?
United States
23
2022
15065
0.320
 Why?
Child, Preschool
31
2016
11142
0.310
 Why?
Faculty, Medical
1
2012
290
0.310
 Why?
Treatment Outcome
16
2025
10965
0.310
 Why?
Interprofessional Relations
3
2021
291
0.310
 Why?
Child Development
1
2014
471
0.300
 Why?
Spirometry
8
2020
260
0.300
 Why?
Group Practice
1
2008
7
0.290
 Why?
Anti-Allergic Agents
2
2008
41
0.290
 Why?
Oxygen
3
2018
976
0.280
 Why?
Aged
22
2022
24237
0.280
 Why?
Computer Simulation
1
2012
997
0.280
 Why?
Dyspnea
3
2022
251
0.260
 Why?
Drug Utilization
4
2005
169
0.250
 Why?
Primary Health Care
5
2025
1778
0.250
 Why?
Follow-Up Studies
17
2017
5167
0.240
 Why?
Primary Graft Dysfunction
2
2017
34
0.240
 Why?
Quality Assurance, Health Care
1
2008
329
0.240
 Why?
Bronchiolitis Obliterans
3
2017
70
0.240
 Why?
Respiratory Sounds
1
2006
109
0.240
 Why?
Gift Giving
1
2005
12
0.230
 Why?
Diagnostic Techniques, Respiratory System
1
2005
5
0.230
 Why?
Allergists
2
2022
11
0.230
 Why?
Genetic Testing
1
2008
457
0.230
 Why?
Randomized Controlled Trials as Topic
7
2020
1516
0.230
 Why?
Delivery of Health Care
2
2021
961
0.220
 Why?
Retrospective Studies
18
2024
15924
0.220
 Why?
Medication Adherence
2
2023
503
0.210
 Why?
Cohort Studies
14
2013
5736
0.210
 Why?
Specialization
2
2025
148
0.210
 Why?
Time Factors
10
2020
6885
0.210
 Why?
Natural Language Processing
1
2025
95
0.210
 Why?
Leadership
2
2022
396
0.210
 Why?
Antibodies, Monoclonal
2
2008
1439
0.210
 Why?
Massachusetts
5
2016
175
0.210
 Why?
Medicine
1
2025
127
0.200
 Why?
Rhinitis, Allergic, Perennial
1
2003
22
0.200
 Why?
Genetic Variation
1
2008
1003
0.200
 Why?
Steroids
8
2011
160
0.200
 Why?
Recurrence
5
2013
1103
0.200
 Why?
Genetic Predisposition to Disease
2
2025
2369
0.200
 Why?
Health Status
1
2008
821
0.190
 Why?
Predictive Value of Tests
9
2012
2045
0.190
 Why?
Multicenter Studies as Topic
4
2018
319
0.190
 Why?
Young Adult
11
2019
13344
0.190
 Why?
Beclomethasone
1
2022
9
0.190
 Why?
Prevalence
4
2022
2746
0.180
 Why?
Models, Theoretical
4
2007
582
0.180
 Why?
Tiotropium Bromide
2
2018
5
0.180
 Why?
Desensitization, Immunologic
1
2022
96
0.180
 Why?
Nebulizers and Vaporizers
2
2020
68
0.180
 Why?
Biomarkers
3
2021
4115
0.180
 Why?
Patient Preference
1
2023
197
0.170
 Why?
Social Class
2
2022
279
0.170
 Why?
Churg-Strauss Syndrome
1
2020
27
0.170
 Why?
Bronchoconstriction
3
2011
31
0.170
 Why?
Pulmonologists
1
2020
14
0.170
 Why?
Granulomatosis with Polyangiitis
1
2020
45
0.160
 Why?
Capacity Building
1
2021
61
0.160
 Why?
Muscarinic Antagonists
1
2020
30
0.160
 Why?
Agammaglobulinemia
1
2020
34
0.160
 Why?
Electronic Health Records
2
2025
1088
0.160
 Why?
Physician-Patient Relations
2
2021
582
0.160
 Why?
Risk Factors
12
2018
10426
0.160
 Why?
Practice Guidelines as Topic
5
2020
1550
0.160
 Why?
Air Pollution, Indoor
2
2002
184
0.150
 Why?
Treatment Adherence and Compliance
1
2019
27
0.150
 Why?
Exercise Test
1
2022
622
0.150
 Why?
Receptors, IgE
2
2009
44
0.150
 Why?
Prognosis
8
2017
4024
0.140
 Why?
Allergens
1
2021
396
0.140
 Why?
Vitamin D
2
2012
399
0.140
 Why?
Fossil Fuels
1
1997
10
0.140
 Why?
Emergency Medical Services
2
2007
565
0.140
 Why?
Hypersensitivity
1
2020
254
0.130
 Why?
Alemtuzumab
1
2017
15
0.130
 Why?
Photopheresis
1
2017
9
0.130
 Why?
Drug Prescriptions
2
2011
259
0.130
 Why?
Biological Products
1
2020
229
0.130
 Why?
Respiration
1
2017
207
0.130
 Why?
Respiration Disorders
1
1997
78
0.130
 Why?
Physicians, Primary Care
3
2021
225
0.130
 Why?
Drug Combinations
3
2012
347
0.130
 Why?
Statistics, Nonparametric
1
2017
431
0.120
 Why?
Aged, 80 and over
6
2019
7699
0.120
 Why?
Drug Therapy, Combination
5
2020
1049
0.120
 Why?
Immunomodulation
1
2017
99
0.120
 Why?
Socioeconomic Factors
4
2022
1310
0.120
 Why?
Breath Tests
2
2008
76
0.120
 Why?
Scopolamine Derivatives
1
2015
3
0.120
 Why?
Patient Admission
1
2018
202
0.120
 Why?
Embolism, Fat
1
2015
11
0.120
 Why?
Tobacco Smoke Pollution
2
2010
258
0.120
 Why?
Immunoglobulin G
1
2020
904
0.120
 Why?
Cholinergic Antagonists
1
2015
24
0.120
 Why?
Transplants
1
2015
40
0.120
 Why?
National Heart, Lung, and Blood Institute (U.S.)
1
2015
98
0.120
 Why?
Fluticasone-Salmeterol Drug Combination
2
2012
8
0.120
 Why?
Carcinoma, Bronchogenic
1
2015
20
0.110
 Why?
Referral and Consultation
1
2021
799
0.110
 Why?
Genomics
2
2018
804
0.110
 Why?
Longitudinal Studies
6
2017
2846
0.110
 Why?
Overweight
2
2011
573
0.110
 Why?
Postoperative Complications
2
2017
2738
0.110
 Why?
Respiratory Tract Infections
2
2012
384
0.110
 Why?
Telemedicine
1
2023
867
0.110
 Why?
Ambulatory Care Information Systems
2
2005
5
0.110
 Why?
Graft Rejection
2
2013
577
0.110
 Why?
Prednisolone
1
2014
68
0.110
 Why?
Guideline Adherence
3
2020
557
0.100
 Why?
Risk
4
2015
913
0.100
 Why?
Education, Medical, Continuing
2
2005
133
0.100
 Why?
Airway Obstruction
1
2015
161
0.100
 Why?
Environmental Exposure
3
2006
568
0.100
 Why?
Quality Improvement
1
2022
1202
0.100
 Why?
Forecasting
1
2015
387
0.100
 Why?
Bronchial Hyperreactivity
3
2010
104
0.100
 Why?
Transplantation
1
2013
35
0.100
 Why?
Office Visits
4
2011
95
0.100
 Why?
Insurance Claim Review
1
2013
84
0.100
 Why?
Peer Group
2
2012
244
0.100
 Why?
Medicare
2
2022
790
0.100
 Why?
Double-Blind Method
5
2010
1947
0.100
 Why?
Growth
1
2012
52
0.100
 Why?
Methacholine Chloride
3
2008
49
0.090
 Why?
Research
1
2015
452
0.090
 Why?
Cytomegalovirus Infections
2
2012
195
0.090
 Why?
Costs and Cost Analysis
1
2013
222
0.090
 Why?
Antibodies, Monoclonal, Humanized
2
2008
817
0.090
 Why?
Cost of Illness
3
2003
308
0.090
 Why?
Metered Dose Inhalers
1
2012
13
0.090
 Why?
Feedback
1
2012
174
0.090
 Why?
Drug Dosage Calculations
1
2011
22
0.090
 Why?
Mycoses
1
2012
82
0.090
 Why?
Logistic Models
5
2017
2089
0.090
 Why?
Antifungal Agents
1
2012
141
0.090
 Why?
Body Height
1
2012
196
0.090
 Why?
Effect Modifier, Epidemiologic
1
2011
10
0.090
 Why?
Multivariate Analysis
7
2017
1498
0.090
 Why?
Professional Role
1
2012
167
0.090
 Why?
Medication Errors
1
2012
96
0.090
 Why?
Morbidity
2
2022
321
0.090
 Why?
Mycobacterium
1
2012
110
0.090
 Why?
Epidemiologic Studies
1
2011
71
0.080
 Why?
Obesity
3
2015
3002
0.080
 Why?
Patient Readmission
1
2016
706
0.080
 Why?
Diagnostic Errors
1
2012
174
0.080
 Why?
Pneumococcal Vaccines
1
2012
135
0.080
 Why?
Secondary Prevention
1
2012
237
0.080
 Why?
Program Development
1
2012
362
0.080
 Why?
Drug Resistance
1
2011
149
0.080
 Why?
Probability
1
2011
309
0.080
 Why?
Lung Diseases
1
2017
783
0.080
 Why?
Vitamin D Deficiency
1
2012
188
0.080
 Why?
Chi-Square Distribution
2
2017
525
0.080
 Why?
Bronchial Provocation Tests
2
2008
51
0.080
 Why?
Fluticasone
2
2008
56
0.080
 Why?
Decision Support Techniques
2
2012
425
0.080
 Why?
Incidence
5
2020
2836
0.080
 Why?
Ambulatory Care
2
2011
575
0.080
 Why?
Receptors, Corticotropin-Releasing Hormone
1
2009
28
0.080
 Why?
Immunoglobulin E
2
2008
326
0.080
 Why?
Vital Capacity
4
2017
304
0.080
 Why?
Algorithms
1
2017
1722
0.080
 Why?
Lectins, C-Type
1
2009
65
0.080
 Why?
Health Services
2
2007
116
0.080
 Why?
Proportional Hazards Models
1
2012
1286
0.080
 Why?
Health Knowledge, Attitudes, Practice
2
2012
1369
0.070
 Why?
Medication Therapy Management
1
2010
77
0.070
 Why?
Surgical Wound Infection
1
2012
311
0.070
 Why?
Cross-Sectional Studies
6
2010
5537
0.070
 Why?
Odds Ratio
4
2017
1084
0.070
 Why?
Kaplan-Meier Estimate
3
2016
903
0.070
 Why?
Acute Disease
1
2011
1011
0.070
 Why?
Pandemics
3
2022
1650
0.070
 Why?
Vitamin K Epoxide Reductases
1
2008
12
0.070
 Why?
Cytochrome P-450 CYP2C9
1
2008
20
0.070
 Why?
Smoking
3
2017
1607
0.070
 Why?
Eosinophil Cationic Protein
1
2008
9
0.070
 Why?
Mixed Function Oxygenases
1
2008
49
0.070
 Why?
Program Evaluation
1
2012
913
0.070
 Why?
Aryl Hydrocarbon Hydroxylases
1
2008
48
0.070
 Why?
Adrenergic beta-Agonists
1
2008
97
0.070
 Why?
Genetic Techniques
1
2008
67
0.070
 Why?
Quality-Adjusted Life Years
2
2006
109
0.070
 Why?
Trastuzumab
1
2008
97
0.070
 Why?
Markov Chains
2
2006
126
0.070
 Why?
Cost Sharing
1
2008
17
0.070
 Why?
Insurance, Pharmaceutical Services
1
2008
24
0.070
 Why?
State Health Plans
1
2008
33
0.070
 Why?
Smoking Cessation
1
2012
434
0.070
 Why?
Antibodies, Anti-Idiotypic
1
2007
51
0.070
 Why?
Reimbursement Mechanisms
1
2008
83
0.070
 Why?
Interviews as Topic
1
2011
806
0.070
 Why?
Omalizumab
1
2007
40
0.070
 Why?
Chronic Disease
3
2017
1802
0.070
 Why?
Exercise Tolerance
2
2022
278
0.070
 Why?
Mycobacterium Infections, Nontuberculous
1
2012
364
0.070
 Why?
Warfarin
1
2008
155
0.070
 Why?
Factor Analysis, Statistical
1
2008
294
0.070
 Why?
Health Surveys
2
2006
521
0.070
 Why?
Health Services Accessibility
2
2021
1005
0.060
 Why?
Influenza Vaccines
1
2012
531
0.060
 Why?
Tomography, X-Ray Computed
1
2017
2706
0.060
 Why?
Databases, Factual
1
2012
1404
0.060
 Why?
Antiviral Agents
1
2012
766
0.060
 Why?
Animals, Domestic
1
2006
16
0.060
 Why?
Lung Diseases, Interstitial
1
2013
644
0.060
 Why?
Animals
2
2025
37352
0.060
 Why?
Receptor, ErbB-2
1
2008
355
0.060
 Why?
Eosinophils
1
2008
322
0.060
 Why?
Physicians, Family
2
2004
195
0.060
 Why?
Biomedical Research
1
2012
699
0.060
 Why?
Health Benefit Plans, Employee
1
2005
27
0.060
 Why?
Database Management Systems
1
2005
51
0.060
 Why?
Models, Biological
1
2012
1818
0.060
 Why?
Hip Fractures
1
2006
86
0.060
 Why?
Health Policy
1
2008
396
0.060
 Why?
Patients
1
2006
180
0.060
 Why?
Insurance Coverage
1
2006
233
0.060
 Why?
Infant
3
2008
9576
0.050
 Why?
Patient Education as Topic
3
2005
763
0.050
 Why?
Utilization Review
1
2004
40
0.050
 Why?
Body Mass Index
3
2015
2388
0.050
 Why?
Clinical Competence
1
2012
1140
0.050
 Why?
Prenatal Exposure Delayed Effects
1
2010
611
0.050
 Why?
Gene Expression Profiling
1
2011
1757
0.050
 Why?
Medicaid
1
2008
448
0.050
 Why?
Mass Screening
1
2012
1287
0.050
 Why?
Anticoagulants
1
2008
669
0.050
 Why?
Sex Factors
3
2016
2056
0.050
 Why?
Nitric Oxide
1
2008
895
0.050
 Why?
Vaccination
1
2012
1435
0.050
 Why?
Attitude to Health
1
2006
458
0.050
 Why?
Anti-Bacterial Agents
2
2004
1812
0.050
 Why?
Clinical Trials as Topic
2
2005
1036
0.050
 Why?
Case Management
1
2003
67
0.050
 Why?
Puerto Rico
1
2022
53
0.050
 Why?
Choice Behavior
1
2004
173
0.050
 Why?
Parents
3
2006
1421
0.050
 Why?
Symptom Flare Up
1
2022
37
0.050
 Why?
Circadian Rhythm
1
2006
490
0.050
 Why?
Sputum
1
2004
304
0.050
 Why?
Academies and Institutes
1
2022
54
0.050
 Why?
Lung Neoplasms
1
2015
2534
0.040
 Why?
Health Services Research
1
2004
405
0.040
 Why?
Minority Groups
1
2003
274
0.040
 Why?
Survival Rate
2
2016
1935
0.040
 Why?
Clinical Trials, Phase II as Topic
1
2020
71
0.040
 Why?
Electronics
1
2021
72
0.040
 Why?
Clinical Trials, Phase III as Topic
1
2020
105
0.040
 Why?
Efficiency
1
2021
101
0.040
 Why?
Sample Size
1
2020
125
0.040
 Why?
Health Care Reform
1
2021
106
0.040
 Why?
Schools, Medical
1
2021
152
0.040
 Why?
Risk Assessment
3
2020
3470
0.040
 Why?
Patient Selection
2
2020
692
0.040
 Why?
Pragmatic Clinical Trials as Topic
1
2020
89
0.040
 Why?
Patient Compliance
2
2016
599
0.040
 Why?
Language
1
2022
303
0.040
 Why?
Stress, Psychological
1
2007
1124
0.040
 Why?
Time
1
2019
88
0.040
 Why?
Cluster Analysis
2
2014
515
0.040
 Why?
Health Education
1
2002
355
0.040
 Why?
Quality of Health Care
1
2003
654
0.040
 Why?
Poland
1
2017
35
0.030
 Why?
Republic of Korea
1
2017
41
0.030
 Why?
Bronchitis, Chronic
1
2017
25
0.030
 Why?
Cooperative Behavior
1
2021
459
0.030
 Why?
Sensitivity and Specificity
3
2013
1959
0.030
 Why?
Patient-Centered Care
1
2003
545
0.030
 Why?
Nitrogen Dioxide
1
1997
47
0.030
 Why?
Geography
1
2018
203
0.030
 Why?
Long-Term Care
1
2018
106
0.030
 Why?
Aftercare
1
2019
213
0.030
 Why?
Pediatrics
1
2005
1076
0.030
 Why?
Monitoring, Physiologic
2
2012
272
0.030
 Why?
Self Concept
1
2019
256
0.030
 Why?
Netherlands
1
2016
86
0.030
 Why?
Antineoplastic Agents
1
2008
2162
0.030
 Why?
Tuberculosis, Pulmonary
1
2017
142
0.030
 Why?
Perception
1
2019
368
0.030
 Why?
Formoterol Fumarate
1
2015
7
0.030
 Why?
Forced Expiratory Flow Rates
1
2015
12
0.030
 Why?
Salmeterol Xinafoate
1
2015
22
0.030
 Why?
Ethanolamines
1
2015
15
0.030
 Why?
Receptors, Adrenergic, beta-2
1
2015
33
0.030
 Why?
Feasibility Studies
1
2020
977
0.030
 Why?
Treatment Failure
1
2016
351
0.030
 Why?
Dose-Response Relationship, Drug
2
2011
2051
0.030
 Why?
Self Efficacy
1
2019
400
0.030
 Why?
Polymorphism, Single Nucleotide
2
2016
2144
0.030
 Why?
Postoperative Period
1
2016
358
0.030
 Why?
Education
1
2015
111
0.030
 Why?
Age Factors
3
2008
3276
0.030
 Why?
Fatal Outcome
1
2015
312
0.030
 Why?
Immunosuppressive Agents
2
2015
868
0.030
 Why?
Biopsy
2
2013
1093
0.030
 Why?
Pilot Projects
1
2020
1763
0.030
 Why?
Patient Acceptance of Health Care
1
2021
855
0.030
 Why?
Combined Modality Therapy
1
2017
1237
0.030
 Why?
Gene Expression
1
2018
1494
0.030
 Why?
Echinocandins
1
2012
7
0.020
 Why?
Telephone
2
2005
181
0.020
 Why?
Lipopeptides
1
2012
14
0.020
 Why?
Aspergillosis
1
2012
22
0.020
 Why?
Amphotericin B
1
2012
33
0.020
 Why?
Intention to Treat Analysis
1
2012
75
0.020
 Why?
Candidiasis
1
2012
63
0.020
 Why?
Tissue Donors
1
2015
423
0.020
 Why?
Transplantation, Homologous
1
2013
415
0.020
 Why?
Mycobacterium avium Complex
1
2012
88
0.020
 Why?
Hypoxia
1
2019
1146
0.020
 Why?
Age Distribution
2
2003
398
0.020
 Why?
Extracorporeal Membrane Oxygenation
1
2015
333
0.020
 Why?
Cromolyn Sodium
2
2001
5
0.020
 Why?
Triazoles
1
2012
156
0.020
 Why?
Leukotriene Antagonists
1
2011
24
0.020
 Why?
Self Care
2
2005
383
0.020
 Why?
Functional Residual Capacity
1
2010
7
0.020
 Why?
Reference Values
1
2012
805
0.020
 Why?
Colorado
1
2021
4532
0.020
 Why?
Costa Rica
1
2010
18
0.020
 Why?
Principal Component Analysis
1
2011
192
0.020
 Why?
Nontuberculous Mycobacteria
1
2012
205
0.020
 Why?
Genome-Wide Association Study
1
2016
1400
0.020
 Why?
Health
1
2010
84
0.020
 Why?
Inhalation
1
2010
29
0.020
 Why?
Environment
1
2011
341
0.020
 Why?
Observation
1
2008
54
0.020
 Why?
Sex Ratio
1
2008
15
0.020
 Why?
Least-Squares Analysis
1
2008
78
0.020
 Why?
Models, Econometric
1
2008
36
0.020
 Why?
Prospective Studies
2
2012
7660
0.020
 Why?
Health Services Administration
1
2007
8
0.020
 Why?
Treatment Refusal
1
2008
96
0.020
 Why?
Social Isolation
1
2007
62
0.020
 Why?
Intelligence
1
2007
129
0.020
 Why?
Puberty
1
2008
152
0.020
 Why?
Body Weight
1
2011
995
0.020
 Why?
Child Behavior Disorders
1
2007
143
0.020
 Why?
Exercise
1
2016
2082
0.010
 Why?
Insurance, Health
1
2007
295
0.010
 Why?
CD4-Positive T-Lymphocytes
1
2011
1101
0.010
 Why?
Genotype
1
2009
1873
0.010
 Why?
Bronchoconstrictor Agents
1
2003
14
0.010
 Why?
Health Status Indicators
1
2004
165
0.010
 Why?
Organizational Innovation
1
2004
139
0.010
 Why?
Case-Control Studies
1
2010
3585
0.010
 Why?
Systems Integration
1
2003
37
0.010
 Why?
Computer Systems
1
2003
51
0.010
 Why?
Motor Activity
1
2007
715
0.010
 Why?
Child Welfare
1
2004
222
0.010
 Why?
Self Disclosure
1
2002
65
0.010
 Why?
Histamine H1 Antagonists
1
2002
28
0.010
 Why?
Drug Administration Schedule
1
2004
769
0.010
 Why?
Administration, Intranasal
1
2002
91
0.010
 Why?
Confidence Intervals
1
2002
336
0.010
 Why?
Regression Analysis
1
2003
1015
0.010
 Why?
Nurse's Role
1
2003
167
0.010
 Why?
Point-of-Care Systems
1
2003
182
0.010
 Why?
Health Care Surveys
1
2002
565
0.010
 Why?
Sex Distribution
1
2001
380
0.010
 Why?
Patient Satisfaction
1
2004
683
0.010
 Why?
Linear Models
1
2002
856
0.010
 Why?
Disease Management
1
2003
620
0.010
 Why?
Decision Support Systems, Clinical
1
2003
239
0.010
 Why?
Caregivers
1
2007
905
0.010
 Why?
Bronchoscopy
1
2000
220
0.010
 Why?
Internet
1
2003
674
0.010
 Why?
Pregnancy
1
2010
6874
0.010
 Why?
Survival Analysis
1
2000
1313
0.010
 Why?
Infant, Newborn
1
2004
6152
0.010
 Why?
Fuhlbrigge's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (429) concept(s)
_
Co-Authors Expand Description
See all (18) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)